PTGER3 and type 2 diabetes mellitus: 2.7. FIE-FTCIR MS Metabolomics Reveals That Elevations in Circulating Eicosanoid Precursors Correlate Directly with Agonist-Dependent EP3 Signaling in T2D β-Cell Dysfunction